by Robert W. Snow
PLoS Med 13(11): e1002176 – Published: November 22, 2016
The authors provide evidence of the dramatic impact on the incidence of malaria of seasonal malaria chemoprevention (SMC) among children aged older than five years, the current recommended upper age limit for SMC. Research on drugs to prevent malaria in Africa among non-pregnant populations has a long history with surprisingly little sustainable policy impact. The last five years of SMC research signal an important stage in drug-based policy for malaria based on evolving field science.